Morphosys AG - ADR

NASDAQ:MOR 3:59:51 PM EDT

5.00

-0.06 (-1.19%)

: $5.03 +0.03 (+0.60%)

Market Cap (Intraday)	683.19M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$53.75 Million
Adjusted EPS	$0.09

See more estimates

10-Day MA	$4.97
50-Day MA	$4.25
200-Day MA	$4.86

See more pivots

Morphosys AG - ADR Stock, NASDAQ:MOR

Semmelweisstrasse 7, Semmelweisstrasse 7, Planegg, Bayern (Bavaria) 82152

Germany

Phone: +49.89.89927.0

Number of Employees: 732

http://www.morphosys.de

Description

MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.